Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites

Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites

Abstract For patients with cirrhosis, no definitive predictor of the efficacy and prognosis of tolvaptan treatment exists. We assessed the cisterna chyli’s utility as an optimal marker. We retrospectively enrolled 172 patients with cirrhosis. The effect of tolvaptan was evaluated using post-treatmen...

Full description

Bibliographic Details
Main Authors: Masashi Hirooka, Yohei Koizumi, Ryo Yano, Yoshiko Nakamura, Koutarou Sunago, Atsushi Yukimoto, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-11889-z

Internet

https://doi.org/10.1038/s41598-022-11889-z

Similar Items